Hu, M., Xu, Q., Zhang, F., Buckland, K. F., Gao, Y., Du, W., . . . An, Y. (2025). Preclinical ex vivo IL2RG gene therapy using autologous hematopoietic stem cells as an effective and safe treatment for X-linked severe combined immunodeficiency disease. Genes and Diseases, 12(3), . https://doi.org/10.1016/j.gendis.2024.101445
Chicago Style (17th ed.) CitationHu, Mingfeng, et al. "Preclinical Ex Vivo IL2RG Gene Therapy Using Autologous Hematopoietic Stem Cells as an Effective and Safe Treatment for X-linked Severe Combined Immunodeficiency Disease." Genes and Diseases 12, no. 3 (2025). https://doi.org/10.1016/j.gendis.2024.101445.
MLA (9th ed.) CitationHu, Mingfeng, et al. "Preclinical Ex Vivo IL2RG Gene Therapy Using Autologous Hematopoietic Stem Cells as an Effective and Safe Treatment for X-linked Severe Combined Immunodeficiency Disease." Genes and Diseases, vol. 12, no. 3, 2025, https://doi.org/10.1016/j.gendis.2024.101445.